Form 8-K - Current report:
SEC Accession No. 0001104659-22-091214
Filing Date
2022-08-15
Accepted
2022-08-15 16:15:27
Documents
15
Period of Report
2022-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2223445d1_8k.htm   iXBRL 8-K 38386
2 EXHIBIT 4.1 tm2223445d1_ex4-1.htm EX-4.1 79079
3 EXHIBIT 10.1 tm2223445d1_ex10-1.htm EX-10.1 583609
7 GRAPHIC tm2223445d1_ex4-1img01.jpg GRAPHIC 2073
  Complete submission text file 0001104659-22-091214.txt   1024570

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA azyo-20220811.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20220811_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20220811_pre.xml EX-101.PRE 22589
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2223445d1_8k_htm.xml XML 3750
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 221165818
SIC: 2836 Biological Products, (No Diagnostic Substances)